
Nanologica Investor Relations Material
Latest events

Q2 2025
10 Jul, 2025

Q1 2025
16 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nanologica
Access all reports
Nanologica AB, a nanotechnology company, develops nanoporous silica for applications in the life science industry. Its technology combines a biologically active component with nano-sized pores to improve the delivery of drugs and vaccines to the target via controlled release mechanisms. The company’s products include Nano-pillars and Nano-spheres that are used in various applications such as biological treatments, diagnostics, or therapeutic medicines, as well as drug formulations in pharmaceuticals and other industries. Nanologica AB was founded in 2004 and is based in Södertälje, Sweden.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NICA
Country
🇸🇪 Sweden